Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease
A protein biomarker discovery workflow was applied to plasma samples from patients at different stages of diabetic kidney disease. The proteomics platform produced a panel of significant plasma biomarkers that were statistically scrutinised against the current gold standard tests on an analysis of 5...
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Elsevier
2017-03-01
|
| Series: | EuPA Open Proteomics |
| Subjects: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2212968516300393 |